Invention Grant
- Patent Title: CGRP receptor antagonists
-
Application No.: US15229249Application Date: 2016-08-05
-
Publication No.: US09708297B2Publication Date: 2017-07-18
- Inventor: David Andrew Coates , Kevin Charles Fortner , Steven Marc Massey , Jason Kenneth Myers , Antonio Navarro , Miles Goodman Siegel , Russell Dean Stucky
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Nelsen L. Lentz
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07C309/04 ; C07D401/12
Abstract:
The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20170044138A1 CGRP RECEPTOR ANTAGONISTS Public/Granted day:2017-02-16
Information query
